How much funding has Restore Medical raised?

Restore Medical has raised $23.0M in total funding, most recently a Series B round.

Where is Restore Medical headquartered?

Restore Medical is headquartered in Or-Yehuda, Israel.

What industry is Restore Medical in?

Restore Medical operates in Healthcare, Medical Devices.

How many employees does Restore Medical have?

Restore Medical has 1-10 employees.

Restore Medical

Q: Who are Restore Medical's investors?

Restore Medical's investors include Pitango Growth, European Innovation Council Fund, Peregrine Ventures.

Revolution in heart failure — the first transcatheter Pulmonary Artery Banding system

Or-Yehuda, Israel · $23.0M raised

Healthcare

Medical Devices

Headquarters: Or-Yehuda
Employees: 1–10
Business Model: B2B
Website: restoremedical.co

Total Funding: $23.0M
Last Round: Series BDec 2024
Rounds: 1

About

Restore Medical is a privately held Israeli clinical-stage medical device company dedicated to transforming the treatment of congestive heart failure (CHF). The company has developed ContraBand™, the first and only transcatheter Pulmonary Artery Banding (PAB) system for treating HFrEF (Heart Failure with reduced Ejection Fraction) patients. ContraBand is a reversible, catheter-delivered implant that leverages the right ventricle to support the left ventricle, improving LV ejection fraction and restoring optimal ventricular geometry. The device received FDA Breakthrough Device Designation in July 2024. Restore Medical secured $23M in funding in 2025 and previously received €2.5M in EU funding plus a €10M EIC equity commitment.

Summary

Restore Medical is a Healthcare company based in Or-Yehuda, Israel. It has raised $23.0M in total across 1 round, most recently a Series B round in Dec 2024. Investors include Pitango Growth, European Innovation Council Fund and Peregrine Ventures.